Growth of human melanoma xenografts is suppressed by systemic angiostatin gene therapy

Monica Rodolfo, Enrica Mira Catò, Sabina Soldati, Roberta Ceruti, Marco Asioli, Eugenio Scanziani, Paolo Vezzoni, Giorgio Parmiani, Maria Grazia Sacco

Research output: Contribution to journalArticle

Abstract

The effect of local and systemic delivery of the angiostatin gene on human melanoma growth was studied in nude mice. Liposome-coated plasmids carrying the cDNA coding for murine and human angiostatin (CMVang and BSHang) were injected weekly, locally or systemically, in mice transplanted with melanoma cells. The treatment reduced melanoma growth by 50% to 90% compared to that occurring in control animals treated with liposome-coated plasmid carrying the lacZ gene or in untreated controls. The growth of both locally injected and controlateral uninjected tumors in mice bearing two melanoma grafts was significantly suppressed after intratumoral treatment. Tumor growth inhibition was also observed in mice treated by intraperitoneal delivery, suggesting that angiostatin gene therapy acts through a systemic effect. Both melanoma growth suppression and delay in the onset of tumor growth were observed in treated mice. PCR performed on tumors and normal tissues showed that the lipofected DNA was present in tissues from treated mice, and angiostatin expression was demonstrated by RT-PCR. Histopathological analysis of melanoma nodules revealed an increase in apoptotic cells and a reduction in vessel density in tumors from treated mice. Our results suggest that systemic, liposome-mediated administration of genes coding for antiangiogenic factors represents a promising strategy for melanoma treatment in humans.

Original languageEnglish
Pages (from-to)491-496
Number of pages6
JournalCancer Gene Therapy
Volume8
Issue number7
DOIs
Publication statusPublished - 2001

Fingerprint

Angiostatins
Heterografts
Genetic Therapy
Melanoma
Growth
Liposomes
Neoplasms
Plasmids
Polymerase Chain Reaction
Lac Operon
Nude Mice
Genes
Therapeutics
Complementary DNA
Transplants
DNA

Keywords

  • Angiostatin
  • Gene therapy
  • Liposomes
  • Melanoma

ASJC Scopus subject areas

  • Cancer Research
  • Genetics

Cite this

Rodolfo, M., Catò, E. M., Soldati, S., Ceruti, R., Asioli, M., Scanziani, E., ... Sacco, M. G. (2001). Growth of human melanoma xenografts is suppressed by systemic angiostatin gene therapy. Cancer Gene Therapy, 8(7), 491-496. https://doi.org/10.1038/sj.cgt.7700331

Growth of human melanoma xenografts is suppressed by systemic angiostatin gene therapy. / Rodolfo, Monica; Catò, Enrica Mira; Soldati, Sabina; Ceruti, Roberta; Asioli, Marco; Scanziani, Eugenio; Vezzoni, Paolo; Parmiani, Giorgio; Sacco, Maria Grazia.

In: Cancer Gene Therapy, Vol. 8, No. 7, 2001, p. 491-496.

Research output: Contribution to journalArticle

Rodolfo, M, Catò, EM, Soldati, S, Ceruti, R, Asioli, M, Scanziani, E, Vezzoni, P, Parmiani, G & Sacco, MG 2001, 'Growth of human melanoma xenografts is suppressed by systemic angiostatin gene therapy', Cancer Gene Therapy, vol. 8, no. 7, pp. 491-496. https://doi.org/10.1038/sj.cgt.7700331
Rodolfo, Monica ; Catò, Enrica Mira ; Soldati, Sabina ; Ceruti, Roberta ; Asioli, Marco ; Scanziani, Eugenio ; Vezzoni, Paolo ; Parmiani, Giorgio ; Sacco, Maria Grazia. / Growth of human melanoma xenografts is suppressed by systemic angiostatin gene therapy. In: Cancer Gene Therapy. 2001 ; Vol. 8, No. 7. pp. 491-496.
@article{e50f25f4299a4e46ad82f987e306f457,
title = "Growth of human melanoma xenografts is suppressed by systemic angiostatin gene therapy",
abstract = "The effect of local and systemic delivery of the angiostatin gene on human melanoma growth was studied in nude mice. Liposome-coated plasmids carrying the cDNA coding for murine and human angiostatin (CMVang and BSHang) were injected weekly, locally or systemically, in mice transplanted with melanoma cells. The treatment reduced melanoma growth by 50{\%} to 90{\%} compared to that occurring in control animals treated with liposome-coated plasmid carrying the lacZ gene or in untreated controls. The growth of both locally injected and controlateral uninjected tumors in mice bearing two melanoma grafts was significantly suppressed after intratumoral treatment. Tumor growth inhibition was also observed in mice treated by intraperitoneal delivery, suggesting that angiostatin gene therapy acts through a systemic effect. Both melanoma growth suppression and delay in the onset of tumor growth were observed in treated mice. PCR performed on tumors and normal tissues showed that the lipofected DNA was present in tissues from treated mice, and angiostatin expression was demonstrated by RT-PCR. Histopathological analysis of melanoma nodules revealed an increase in apoptotic cells and a reduction in vessel density in tumors from treated mice. Our results suggest that systemic, liposome-mediated administration of genes coding for antiangiogenic factors represents a promising strategy for melanoma treatment in humans.",
keywords = "Angiostatin, Gene therapy, Liposomes, Melanoma",
author = "Monica Rodolfo and Cat{\`o}, {Enrica Mira} and Sabina Soldati and Roberta Ceruti and Marco Asioli and Eugenio Scanziani and Paolo Vezzoni and Giorgio Parmiani and Sacco, {Maria Grazia}",
year = "2001",
doi = "10.1038/sj.cgt.7700331",
language = "English",
volume = "8",
pages = "491--496",
journal = "Cancer Gene Therapy",
issn = "0929-1903",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Growth of human melanoma xenografts is suppressed by systemic angiostatin gene therapy

AU - Rodolfo, Monica

AU - Catò, Enrica Mira

AU - Soldati, Sabina

AU - Ceruti, Roberta

AU - Asioli, Marco

AU - Scanziani, Eugenio

AU - Vezzoni, Paolo

AU - Parmiani, Giorgio

AU - Sacco, Maria Grazia

PY - 2001

Y1 - 2001

N2 - The effect of local and systemic delivery of the angiostatin gene on human melanoma growth was studied in nude mice. Liposome-coated plasmids carrying the cDNA coding for murine and human angiostatin (CMVang and BSHang) were injected weekly, locally or systemically, in mice transplanted with melanoma cells. The treatment reduced melanoma growth by 50% to 90% compared to that occurring in control animals treated with liposome-coated plasmid carrying the lacZ gene or in untreated controls. The growth of both locally injected and controlateral uninjected tumors in mice bearing two melanoma grafts was significantly suppressed after intratumoral treatment. Tumor growth inhibition was also observed in mice treated by intraperitoneal delivery, suggesting that angiostatin gene therapy acts through a systemic effect. Both melanoma growth suppression and delay in the onset of tumor growth were observed in treated mice. PCR performed on tumors and normal tissues showed that the lipofected DNA was present in tissues from treated mice, and angiostatin expression was demonstrated by RT-PCR. Histopathological analysis of melanoma nodules revealed an increase in apoptotic cells and a reduction in vessel density in tumors from treated mice. Our results suggest that systemic, liposome-mediated administration of genes coding for antiangiogenic factors represents a promising strategy for melanoma treatment in humans.

AB - The effect of local and systemic delivery of the angiostatin gene on human melanoma growth was studied in nude mice. Liposome-coated plasmids carrying the cDNA coding for murine and human angiostatin (CMVang and BSHang) were injected weekly, locally or systemically, in mice transplanted with melanoma cells. The treatment reduced melanoma growth by 50% to 90% compared to that occurring in control animals treated with liposome-coated plasmid carrying the lacZ gene or in untreated controls. The growth of both locally injected and controlateral uninjected tumors in mice bearing two melanoma grafts was significantly suppressed after intratumoral treatment. Tumor growth inhibition was also observed in mice treated by intraperitoneal delivery, suggesting that angiostatin gene therapy acts through a systemic effect. Both melanoma growth suppression and delay in the onset of tumor growth were observed in treated mice. PCR performed on tumors and normal tissues showed that the lipofected DNA was present in tissues from treated mice, and angiostatin expression was demonstrated by RT-PCR. Histopathological analysis of melanoma nodules revealed an increase in apoptotic cells and a reduction in vessel density in tumors from treated mice. Our results suggest that systemic, liposome-mediated administration of genes coding for antiangiogenic factors represents a promising strategy for melanoma treatment in humans.

KW - Angiostatin

KW - Gene therapy

KW - Liposomes

KW - Melanoma

UR - http://www.scopus.com/inward/record.url?scp=0034910635&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034910635&partnerID=8YFLogxK

U2 - 10.1038/sj.cgt.7700331

DO - 10.1038/sj.cgt.7700331

M3 - Article

C2 - 11498770

AN - SCOPUS:0034910635

VL - 8

SP - 491

EP - 496

JO - Cancer Gene Therapy

JF - Cancer Gene Therapy

SN - 0929-1903

IS - 7

ER -